Will your business have to go through the new Office of Health Care Affordability (OHCA) reporting regime for material healthcare transactions? What would such a filing involve, and how long would it take to complete the process? Those questions will be among key discussion items addressed in Sheppard Mullin’s upcoming webinar on February 7, 2024, co-sponsored with America’s Physician Groups and Moss Adams LLP. As we have highlighted in our blog series[1] on SB 184 and OHCA throughout the past year, OHCA’s recently finalized cost and market impact review (CMIR) regulations set forth the framework for OHCA’s authority to receive advance notice of and review a large scope of healthcare transactions in the coming months, reflecting a dramatic change to California’s healthcare regulatory landscape moving forward. Please tune in to this important webinar where our knowledgeable presenters will present an overview of the key components and practical considerations surrounding this new law, including:
- Who is subject to the reporting requirement?
- How much will this cost?
- The submission process and what a good submission should look like
- What to expect from the review process
- What is the role and interaction with other possible agencies?
- What you need to know about confidentiality with respect to submissions
- How do you contemplate doing business in California given these developments?
We encourage all stakeholders in the health care space contemplating transactions, mergers, and acquisitions involving a 10% or more change in ownership, asset sale transactions, joint ventures, debt financings, and other strategic transactions to attend this webinar.
Upon conclusion of the program, registrants will receive a white paper from the co-hosts on “Health Care’s Perfect Storm of 2024: Federal Antitrust Enforcement Actions Combine with State Regulatory Developments to Create a Potential Tidal Wave of Deal Scrutiny.”
The panel discussion will be moderated by Eric Klein, partner and leader of Sheppard Mullin’s 200+ attorney national healthcare practice team. Eric will be joined by Bill Barcellona, EVP for Government Affairs with America’s Physician Groups, Chris Prichard, Partner and Health Care Industry Group Leader with Moss Adams LLP, Karl Rebay, Partner, Health Care Consulting, Strategy and Integration Leader with Moss Adams LLP, and Jordan Grushkin, Senior Associate and Leader of Firmwide OHCA Initiatives with Sheppard Mullin.
FOOTNOTES
[1] See links to Sheppard Mullin’s blog series re SB 184 and OHCA:
- California Office of Health Care Affordability: Another Regulatory Hurdle for California Healthcare M&A Transactions?, published 3/3/23.
- Update from California’s Office of Health Care Affordability (OHCA): Proposed Regulations re Material Change Transactions and Pre-Transaction Review, published 8/3/23.
- Public Workshop for OHCA’s Proposed Regulations Sparks Lively Discussion Among Industry Stakeholders, published 9/7/23.
- OHCA’s Revised Regulations Following Comments from Industry Stakeholders, published 10/24/23
- OHCA Published Near-Final Draft of Regulations Requiring Notice and Review of Material Healthcare Transactions in 2024, published 12/6/23.
- The Stage is Set: California Finalizes OHCA Regulations Requiring Notice and Review of Material Healthcare Transactions in 2024, published 1/2/23.